Atlas Trials

Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms

Clinical trial NCT03005119 · UNKNOWN

Trial details

NCT number
NCT03005119
Sponsor
PhytoTech Therapeutics, Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2018-03-01
Primary completion
2018-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.